Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Veracyte, Inc. (VCYT) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Veracyte, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1384101.
Total stock buying since 2015: $1,034,366.
Total stock sales since 2015: $173,218,648.
Total stock option exercises since 2015: $17,272,340.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 84,739 | $2,778,645 | 20,000 | $160,799 |
| 2024 | 0 | $0 | 179,336 | $6,302,925 | 27,500 | $250,723 |
| 2023 | 0 | $0 | 259,416 | $6,772,337 | 195,247 | $1,727,780 |
| 2022 | 60,000 | $980,100 | 128,769 | $3,320,151 | 115,495 | $1,054,496 |
| 2021 | 0 | $0 | 237,012 | $83,387,963 | 278,164 | $2,511,919 |
| 2020 | 0 | $0 | 660,429 | $21,362,715 | 606,862 | $6,405,200 |
| 2019 | 0 | $0 | 1,804,335 | $40,341,088 | 718,122 | $4,587,492 |
| 2018 | 0 | $0 | 716,305 | $7,854,967 | 265,305 | $463,718 |
| 2017 | 0 | $0 | 111,726 | $935,400 | 59,541 | $94,934 |
| 2016 | 10,000 | $54,266 | 0 | $0 | 0 | $0 |
| 2015 | 0 | $0 | 19,500 | $162,457 | 19,500 | $15,279 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-06 | 0 | $0 | 9,179 | $244,752 | 0 | $0 |
| 2025-03 | 0 | $0 | 69,287 | $2,316,341 | 0 | $0 |
| 2025-02 | 0 | $0 | 6,273 | $217,552 | 0 | $0 |
| 2025-01 | 0 | $0 | 0 | $0 | 20,000 | $160,799 |
| 2024-12 | 0 | $0 | 37,229 | $1,630,706 | 0 | $0 |
| 2024-11 | 0 | $0 | 50,038 | $1,932,621 | 15,000 | $120,599 |
| 2024-09 | 0 | $0 | 10,652 | $345,424 | 0 | $0 |
| 2024-08 | 0 | $0 | 59,731 | $1,888,871 | 10,000 | $104,099 |
| 2024-07 | 0 | $0 | 13,777 | $341,925 | 0 | $0 |
| 2024-06 | 0 | $0 | 6,370 | $131,059 | 2,500 | $26,025 |
| 2024-05 | 0 | $0 | 1,539 | $32,319 | 0 | $0 |
| 2023-07 | 0 | $0 | 76,737 | $2,312,294 | 20,000 | $127,400 |
| 2023-06 | 0 | $0 | 5,893 | $157,679 | 0 | $0 |
| 2023-05 | 0 | $0 | 1,539 | $39,875 | 0 | $0 |
| 2023-04 | 0 | $0 | 34,000 | $749,360 | 34,000 | $190,740 |
| 2023-03 | 0 | $0 | 34,000 | $773,874 | 34,000 | $190,740 |
| 2023-02 | 0 | $0 | 10,000 | $250,000 | 10,000 | $121,199 |
| 2023-01 | 0 | $0 | 97,247 | $2,489,255 | 97,247 | $1,097,701 |
| 2022-12 | 0 | $0 | 81,023 | $2,284,051 | 80,000 | $798,000 |
| 2022-11 | 0 | $0 | 1,023 | $25,575 | 0 | $0 |
| 2022-10 | 0 | $0 | 0 | $0 | 11,088 | $99,293 |
| 2022-06 | 60,000 | $980,100 | 23,720 | $419,348 | 15,000 | $110,850 |
| 2022-03 | 0 | $0 | 23,003 | $591,177 | 4,407 | $26,353 |
| 2022-01 | 0 | $0 | 0 | $0 | 5,000 | $20,000 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-06-13 | Bhanji Muna (Director) | Sale | 4,589 | 26.66 | 122,365 |
| 2025-06-13 | Eastham Karin (Director) | Sale | 4,590 | 26.66 | 122,387 |
| 2025-03-07 | Leite John (Chief Commercial Officer-CLIA) | Sale | 7,411 | 31.50 | 233,424 |
| 2025-03-04 | Mcguire Annie (SVP, General Counsel) | Sale | 1,142 | 33.69 | 38,476 |
| 2025-03-04 | Febbo Phillip G. (Chief Scientific & Med Officer) | Sale | 8,037 | 33.41 | 268,500 |
| 2025-03-04 | Stapley Marc (Chief Executive Officer) | Sale | 52,697 | 33.70 | 1,775,941 |
| 2025-02-27 | Leite John (Chief Commercial Officer-CLIA) | Sale | 5,746 | 33.84 | 194,444 |
| 2025-02-03 | Chambers Rebecca (Chief Financial Officer) | Sale | 527 | 43.85 | 23,108 |
| 2025-01-06 | Epstein Robert S (Director) | Option Ex | 20,000 | 8.04 | 160,799 |
| 2024-12-13 | Stapley Marc (Chief Executive Officer) | Sale | 5,590 | 43.76 | 244,590 |
| 2024-12-04 | Mcguire Annie (SVP, General Counsel) | Sale | 18,699 | 44.02 | 823,186 |
| 2024-12-04 | Febbo Phillip G. (Chief Scientific & Med Officer) | Sale | 3,934 | 44.09 | 173,446 |
| 2024-12-03 | Leite John (Chief Commercial Officer-CLIA) | Sale | 1,050 | 43.25 | 45,408 |
| 2024-12-03 | Chambers Rebecca (Chief Financial Officer) | Sale | 7,000 | 43.23 | 302,624 |
| 2024-12-03 | Wygant Jonathan (VP, Chief Accounting Officer) | Sale | 956 | 43.36 | 41,452 |
| 2024-11-27 | Wygant Jonathan (VP, Chief Accounting Officer) | Sale | 5,032 | 42.89 | 215,832 |
| 2024-11-19 | Eastham Karin (Director) | Sale | 14,731 | 37.76 | 556,301 |
| 2024-11-12 | Chambers Rebecca (Chief Financial Officer) | Sale | 15,275 | 38.34 | 585,658 |
| 2024-11-12 | Epstein Robert S (Director) | Sale | 15,000 | 38.32 | 574,830 |
| 2024-11-12 | Epstein Robert S (Director) | Option Ex | 15,000 | 8.04 | 120,599 |
| 2024-09-19 | Jones Evan/ Fa (Director) | Sale | 5,173 | 35.23 | 182,265 |
| 2024-09-04 | Leite John (Chief Commercial Officer-CLIA) | Sale | 5,479 | 29.78 | 163,159 |
| 2024-08-13 | Jones Evan/ Fa (Director) | Sale | 47,645 | 32.10 | 1,529,595 |
| 2024-08-13 | Jones Evan/ Fa (Director) | Option Ex | 8,486 | 10.41 | 88,339 |
| 2024-08-12 | Jones Evan/ Fa (Director) | Sale | 200 | 30.00 | 6,001 |
| 2024-08-09 | Jones Evan/ Fa (Director) | Sale | 1,778 | 30.03 | 53,391 |
| 2024-08-09 | Jones Evan/ Fa (Director) | Option Ex | 300 | 10.41 | 3,123 |
| 2024-08-07 | Holstein Jens (Director) | Sale | 5,000 | 29.00 | 145,000 |
| 2024-08-07 | Jones Evan/ Fa (Director) | Sale | 5,108 | 30.32 | 154,884 |
| 2024-08-07 | Jones Evan/ Fa (Director) | Option Ex | 1,214 | 10.41 | 12,637 |
| 2024-07-16 | Leite John (Chief Commercial Officer-CLIA) | Sale | 1,277 | 25.00 | 31,925 |
| 2024-07-16 | Holstein Jens (Director) | Sale | 5,000 | 24.50 | 122,500 |
| 2024-07-16 | Eastham Karin (Director) | Sale | 7,500 | 25.00 | 187,500 |
| 2024-06-10 | Bhanji Muna (Director) | Sale | 3,870 | 20.32 | 78,634 |
| 2024-06-07 | Eastham Karin (Director) | Sale | 2,500 | 20.97 | 52,425 |
| 2024-06-07 | Eastham Karin (Director) | Option Ex | 2,500 | 10.41 | 26,025 |
| 2024-05-28 | Bhanji Muna (Director) | Sale | 1,539 | 21.00 | 32,319 |
| 2023-07-19 | Jones Evan/ Fa (Director) | Sale | 3,928 | 30.16 | 118,452 |
| 2023-07-18 | Bishop John L (Director) | Sale | 10,000 | 30.50 | 305,000 |
| 2023-07-18 | Bishop John L (Director) | Option Ex | 10,000 | 6.37 | 63,700 |
| 2023-07-18 | Jones Evan/ Fa (Director) | Sale | 9,765 | 30.17 | 294,639 |
| 2023-07-17 | Bishop John L (Director) | Sale | 10,000 | 30.00 | 300,000 |
| 2023-07-17 | Bishop John L (Director) | Option Ex | 10,000 | 6.37 | 63,700 |
| 2023-07-17 | Jones Evan/ Fa (Director) | Sale | 43,044 | 30.07 | 1,294,203 |
| 2023-06-16 | Bhanji Muna (Director) | Sale | 5,893 | 26.76 | 157,679 |
| 2023-05-30 | Bhanji Muna | Sale | 1,539 | 25.91 | 39,875 |
| 2023-04-14 | Anderson Bonnie H | Sale | 34,000 | 22.04 | 749,360 |
| 2023-04-14 | Anderson Bonnie H | Option Ex | 34,000 | 5.61 | 190,740 |
| 2023-03-15 | Anderson Bonnie H | Sale | 34,000 | 22.76 | 773,874 |
| 2023-03-15 | Anderson Bonnie H | Option Ex | 34,000 | 5.61 | 190,740 |
| 2023-02-28 | Eastham Karin | Sale | 10,000 | 25.00 | 250,000 |
| 2023-02-28 | Eastham Karin | Option Ex | 10,000 | 12.12 | 121,199 |
| 2023-01-17 | Anderson Bonnie H | Sale | 34,000 | 26.47 | 900,048 |
| 2023-01-17 | Anderson Bonnie H | Option Ex | 34,000 | 5.61 | 190,740 |
| 2023-01-11 | Anderson Bonnie H | Sale | 63,247 | 25.13 | 1,589,207 |
| 2023-01-11 | Anderson Bonnie H | Option Ex | 63,247 | 14.34 | 906,961 |
| 2022-12-06 | Kennedy Giulia C (Chief Scientific & Med Officer) | Sale | 1,023 | 27.03 | 27,651 |
| 2022-12-01 | Anderson Bonnie H (Executive Chairwoman) | Sale | 80,000 | 28.20 | 2,256,400 |
| 2022-12-01 | Anderson Bonnie H (Executive Chairwoman) | Option Ex | 80,000 | 9.97 | 798,000 |
| 2022-11-04 | Kennedy Giulia C (Chief Scientific & Med Officer) | Sale | 1,023 | 25.00 | 25,575 |
| 2022-10-13 | Anderson Bonnie H (Executive Chairwoman) | Option Ex | 11,088 | 8.96 | 99,293 |
| 2022-06-14 | Holstein Jens | Sale | 8,720 | 16.27 | 141,848 |
| 2022-06-10 | Stapley Marc (Chief Executive Officer) | Buy | 60,000 | 16.34 | 980,100 |
| 2022-06-08 | Gordon Kevin K | Sale | 15,000 | 18.50 | 277,500 |
| 2022-06-08 | Gordon Kevin K | Option Ex | 15,000 | 7.39 | 110,850 |
| 2022-03-04 | Kennedy Giulia C (Chief Scientific & Med Officer) | Sale | 23,003 | 25.70 | 591,177 |
| 2022-03-04 | Kennedy Giulia C (Chief Scientific & Med Officer) | Option Ex | 4,407 | 5.98 | 26,353 |
| 2022-01-11 | Jones Evan/ Fa | Option Ex | 5,000 | 4.00 | 20,000 |
| 2021-12-17 | Eastham Karin | Sale | 5,000 | 45.00 | 225,000 |
| 2021-12-17 | Eastham Karin | Option Ex | 5,000 | 12.12 | 60,599 |
| 2021-12-09 | Anderson Bonnie H (Executive Chairwoman) | Option Ex | 11,286 | 8.86 | 99,993 |
| 2021-12-07 | Kennedy Giulia C (Chief Scientific & Med Officer) | Sale | 6,125 | 40.62 | 248,797 |
| 2021-12-07 | Kennedy Giulia C (Chief Scientific & Med Officer) | Option Ex | 6,125 | 25.62 | 156,922 |
| 2021-12-06 | Kennedy Giulia C (Chief Scientific & Med Officer) | Sale | 9,232 | 36.25 | 334,623 |
| 2021-12-06 | Kennedy Giulia C (Chief Scientific & Med Officer) | Option Ex | 8,156 | 13.10 | 106,802 |
| 2021-11-01 | Eastham Karin | Sale | 4,400 | 16,370.74 | 72,031,238 |
| 2021-09-17 | Anderson Bonnie H (Executive Chairwoman) | Sale | 2,600 | 50.18 | 130,478 |
| 2021-09-10 | Anderson Bonnie H (Executive Chairwoman) | Sale | 1,900 | 50.03 | 95,049 |
| 2021-09-08 | Kennedy Giulia C (Chief Scientific & Med Officer) | Sale | 926 | 50.53 | 46,790 |
| 2021-09-07 | Kennedy Giulia C (Chief Scientific & Med Officer) | Sale | 12,531 | 50.88 | 637,527 |
| 2021-09-07 | Kennedy Giulia C (Chief Scientific & Med Officer) | Option Ex | 12,531 | 16.96 | 212,525 |
| 2021-08-02 | Eastham Karin | Sale | 4,400 | 44.06 | 193,859 |
| 2021-06-23 | Kennedy Giulia C (Chief Scientific & Med Officer) | Sale | 4,375 | 39.75 | 173,915 |
| 2021-06-23 | Kennedy Giulia C (Chief Scientific & Med Officer) | Option Ex | 4,375 | 24.69 | 108,018 |
| 2021-06-04 | Kennedy Giulia C (Chief Scientific & Med Officer) | Sale | 9,081 | 34.28 | 311,305 |
| 2021-06-04 | Kennedy Giulia C (Chief Scientific & Med Officer) | Option Ex | 8,156 | 13.10 | 106,802 |
| 2021-05-17 | Anderson Bonnie H (Chairman and CEO) | Option Ex | 14,065 | 5.61 | 78,904 |
| 2021-05-03 | Eastham Karin | Sale | 4,427 | 49.01 | 216,980 |
| 2021-03-04 | Kennedy Giulia C (Chief Scientific & Med Officer) | Sale | 52,015 | 51.39 | 2,672,894 |
| 2021-03-04 | Kennedy Giulia C (Chief Scientific & Med Officer) | Option Ex | 30,970 | 14.98 | 464,023 |
| 2021-01-22 | Jones Evan/ Fa | Option Ex | 5,000 | 2.36 | 11,800 |
| 2021-01-20 | Ho Mark (Other) | Option Ex | 52,500 | 5.70 | 298,987 |
| 2021-01-13 | Anderson Bonnie H (Chairman and CEO) | Sale | 18,541 | 50.95 | 944,663 |
| 2021-01-13 | Anderson Bonnie H (Chairman and CEO) | Option Ex | 18,541 | 5.61 | 104,015 |
| 2021-01-12 | Anderson Bonnie H (Chairman and CEO) | Sale | 20,354 | 50.42 | 1,026,309 |
| 2021-01-12 | Anderson Bonnie H (Chairman and CEO) | Option Ex | 20,354 | 5.61 | 114,185 |
| 2021-01-11 | Anderson Bonnie H (Chairman and CEO) | Sale | 71,105 | 50.76 | 3,609,076 |
| 2021-01-11 | Anderson Bonnie H (Chairman and CEO) | Option Ex | 71,105 | 7.24 | 514,444 |
| 2021-01-04 | Gordon Kevin K (Director) | Sale | 10,000 | 48.95 | 489,460 |
| 2021-01-04 | Gordon Kevin K (Director) | Option Ex | 10,000 | 7.39 | 73,900 |
| 2020-12-29 | Anderson Bonnie H (Chairman and CEO) | Option Ex | 31,313 | 3.34 | 104,585 |
| 2020-12-04 | Kennedy Giulia C (Chief Scientific & Med Officer) | Sale | 14,015 | 56.73 | 795,056 |
| 2020-12-04 | Kennedy Giulia C (Chief Scientific & Med Officer) | Option Ex | 13,468 | 11.75 | 158,208 |
| 2020-11-12 | Gordon Kevin K (Director) | Sale | 10,000 | 47.40 | 474,000 |
| 2020-11-12 | Gordon Kevin K (Director) | Option Ex | 10,000 | 7.39 | 73,900 |
| 2020-11-11 | Ho Mark (Other) | Sale | 13,875 | 45.00 | 624,375 |
| 2020-11-10 | Anderson Bonnie H (Chairman and CEO) | Option Ex | 40,000 | 35.70 | 1,427,960 |
| 2020-11-06 | Hanna John Walter Jr (Chief Commercial Officer) | Sale | 21,250 | 43.79 | 930,622 |
| 2020-11-06 | Hanna John Walter Jr (Chief Commercial Officer) | Option Ex | 21,250 | 20.21 | 429,462 |
| 2020-11-05 | Hanna John Walter Jr (Chief Commercial Officer) | Sale | 6,406 | 41.21 | 264,004 |
| 2020-11-05 | Hanna John Walter Jr (Chief Commercial Officer) | Option Ex | 6,406 | 7.51 | 48,141 |
| 2020-10-20 | Ho Mark (Other) | Option Ex | 7,500 | 6.45 | 48,375 |
| 2020-10-19 | Cohen Fred E (Director) | Option Ex | 10,000 | 7.60 | 76,000 |
| 2020-10-08 | Anderson Bonnie H (Chairman and CEO) | Sale | 50,000 | 38.00 | 1,900,000 |
| 2020-10-08 | Anderson Bonnie H (Chairman and CEO) | Option Ex | 50,000 | 8.86 | 443,000 |
| 2020-10-06 | Kennedy Giulia C (Chief Scientific & Med Officer) | Sale | 2,500 | 35.21 | 88,025 |
| 2020-10-06 | Kennedy Giulia C (Chief Scientific & Med Officer) | Option Ex | 2,500 | 20.21 | 50,525 |
| 2020-09-10 | Anderson Bonnie H (Chairman and CEO) | Sale | 20,000 | 31.04 | 620,780 |
| 2020-09-10 | Anderson Bonnie H (Chairman and CEO) | Option Ex | 20,000 | 8.86 | 177,200 |
| 2020-09-04 | Kennedy Giulia C (Chief Scientific & Med Officer) | Sale | 7,027 | 31.16 | 218,996 |
| 2020-09-04 | Kennedy Giulia C (Chief Scientific & Med Officer) | Option Ex | 6,479 | 7.51 | 48,689 |
| 2020-08-31 | Hanna John Walter Jr (Chief Commercial Officer) | Sale | 56,443 | 33.57 | 1,894,904 |
| 2020-08-31 | Hanna John Walter Jr (Chief Commercial Officer) | Option Ex | 56,443 | 8.11 | 457,922 |
| 2020-08-21 | Hanna John Walter Jr (Chief Commercial Officer) | Sale | 1,400 | 36.00 | 50,405 |
| 2020-08-21 | Hanna John Walter Jr (Chief Commercial Officer) | Option Ex | 1,400 | 8.86 | 12,404 |
| 2020-08-10 | Anderson Bonnie H (Chairman and CEO) | Option Ex | 40,000 | 20.54 | 821,680 |
| 2020-08-03 | Jones Evan/ Fa (Director) | Sale | 20,000 | 35.36 | 707,240 |
| 2020-07-31 | Hanna John Walter Jr (Chief Commercial Officer) | Sale | 14,095 | 36.12 | 509,139 |
| 2020-07-31 | Hanna John Walter Jr (Chief Commercial Officer) | Option Ex | 14,095 | 8.86 | 124,881 |
| 2020-07-31 | Kennedy Giulia C (Chief Scientific & Med Officer) | Sale | 20,000 | 35.34 | 706,700 |
| 2020-07-31 | Kennedy Giulia C (Chief Scientific & Med Officer) | Option Ex | 20,000 | 20.21 | 404,200 |
| 2020-07-31 | Jones Evan/ Fa (Director) | Sale | 20,000 | 35.86 | 717,200 |
| 2020-07-30 | Anderson Bonnie H (Chairman and CEO) | Sale | 11,365 | 32.24 | 366,396 |
| 2020-07-30 | Anderson Bonnie H (Chairman and CEO) | Option Ex | 11,365 | 8.86 | 100,693 |
| 2020-07-23 | Anderson Bonnie H (Chairman and CEO) | Sale | 3,280 | 32.05 | 105,107 |
| 2020-07-23 | Anderson Bonnie H (Chairman and CEO) | Option Ex | 3,280 | 8.86 | 29,060 |
| 2020-07-22 | Anderson Bonnie H (Chairman and CEO) | Sale | 100 | 32.00 | 3,200 |
| 2020-07-22 | Anderson Bonnie H (Chairman and CEO) | Option Ex | 100 | 8.86 | 886 |
| 2020-07-21 | Hanna John Walter Jr (Chief Commercial Officer) | Sale | 653 | 32.36 | 21,131 |
| 2020-07-21 | Hanna John Walter Jr (Chief Commercial Officer) | Option Ex | 653 | 2.40 | 1,567 |
| 2020-07-21 | Anderson Bonnie H (Chairman and CEO) | Sale | 3,447 | 32.09 | 110,614 |
| 2020-07-21 | Anderson Bonnie H (Chairman and CEO) | Option Ex | 3,447 | 8.86 | 30,540 |
| 2020-07-20 | Hanna John Walter Jr (Chief Commercial Officer) | Sale | 11,294 | 32.05 | 361,995 |
| 2020-07-20 | Hanna John Walter Jr (Chief Commercial Officer) | Option Ex | 11,294 | 2.40 | 27,105 |
| 2020-07-20 | Anderson Bonnie H (Chairman and CEO) | Sale | 20,349 | 32.04 | 651,920 |
| 2020-07-20 | Anderson Bonnie H (Chairman and CEO) | Option Ex | 20,349 | 6.43 | 130,844 |
| 2020-07-15 | Jones Evan/ Fa (Director) | Sale | 10,000 | 30.23 | 302,290 |
| 2020-07-14 | Jones Evan/ Fa (Director) | Sale | 20,000 | 28.41 | 568,200 |
| 2020-07-13 | Kennedy Giulia C (Chief Scientific & Med Officer) | Sale | 16,738 | 29.66 | 496,365 |
| 2020-07-13 | Kennedy Giulia C (Chief Scientific & Med Officer) | Option Ex | 16,738 | 9.79 | 163,865 |
Insider trading activities including stock purchases, stock sales, and option exercises of VCYT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Veracyte, Inc. (symbol VCYT, CIK number 1384101) see the Securities and Exchange Commission (SEC) website.